Introduction to AspenTech Pharma Suite
GlaxoSmithKline (GSK) has successfully implemented Aspen Mtell® from AspenTech to bolster the resilience and reliability of their pharmaceutical supply chains. By leveraging predictive and prescriptive maintenance solutions offered by AspenTech, GSK has managed to proactively address potential issues, thus avoiding unplanned production downtime.
Key Benefits of Aspen Mtell for GSK
The implementation of Aspen Mtell has yielded significant results for GSK, including providing 35 days of advance warning for potential issues. This advanced warning system has enabled GSK to avert tens of millions of USD in lost batches, ensuring continuous production and supply chain efficiency. Additionally, GSK has experienced a remarkable 50% reduction in lifecycle maintenance costs, contributing to overall cost savings and operational efficiency. With 30 sites across 18 countries covered, GSK has maximized the value gained from AspenTech's innovative technology.
Future-Ready Supply Chain Empowerment
AspenTech's technology plays a pivotal role in empowering GSK to create a reliable and future-ready supply chain. By integrating predictive and prescriptive maintenance solutions, GSK has enhanced their operational agility, minimized production disruptions, and optimized asset performance. This strategic partnership between AspenTech and GSK underscores the importance of leveraging cutting-edge technology to navigate the evolving landscape of the pharmaceutical industry.